<?xml version="1.0" encoding="UTF-8"?>
<p id="par0140">Clinicians must be aware that all adverse reactions and contraindications described for the administration of human plasma can also take place in treatment with this product; in particular Blood Establishments should remind treating physicians of:
 <list list-type="simple" id="lis0015">
  <list-item id="lsti0055">
   <label>-</label>
   <p id="par0145">the absolute contraindication of administering human plasma to patients with a complete IgA deficit (we recommend to test for IgA before the beginning of plasma administration),</p>
  </list-item>
  <list-item id="lsti0060">
   <label>-</label>
   <p id="par0150">the caution for a possible onset of transfusion associated circulatory overload (TACO).</p>
  </list-item>
 </list>
</p>
